| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |